Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
Hentzien M., Bonnet F., Bernasconi E., Biver E., Braun D.L., Munting A., Leuzinger K., Leleux O., Musardo S., Prendki V. et al., 2024/03/19. BMC infectious diseases, 24 (1) p. 329. Peer-reviewed.
ici le détail